Presentations

All Investor presentations Scientific presentations
Investor presentations

2021-11-24

Alzinova at Aktieportföljen

On November 24 our CEO Kristina Torfgård, presented Alzinova at Aktieportföljen. Read more
Investor presentations

2021-11-11

CEO Kristina Torfgård presented at Redeye Life Science Day

Read more
Investor presentations

2021-10-20

Redeye Interview with CEO Kristina Torfgård

Alzinova's CEO Kristina Torfgård was interviewed on October 13, 2021 by Redeye’s Life Science analyst Kevin Sule. Read more
Investor presentations

2021-10-13

Alzinova at Redeye Neurology (CNS) Seminar October 13th

Our CEO, Kristina Torfgård, presented the company at the Redeye Neurology Seminar together with representatives from the other Swedish… Read more
Investor presentations

2021-10-11

Alzinova presented at Aktiedagen Stockholm

Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, October 11 2021. Read more
Investor presentations

2021-09-24

Alzinova presented at Redeye Investor Forum

CEO Kristina Torfgård presented at Redeye Investor Forum, September 23 2021. Read more
Investor presentations

2021-06-02

CEO Kristina Torfgård presented at Redeye Growth Day 2021

Read more
Investor presentations

2021-05-17

Alzinova presented at Aktiektiedagen Göteborg

Read more
Investor presentations

2021-05-05

Alzinova at the Captario Webinar

Read more
Investor presentations

2021-04-29

Alzinova Presented at Redeye Investor Forum April 29th

Read more
Investor presentations

Webcast with CEOs of Swedish Alzheimer’s companies

Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more
Investor presentations

2021-03-01

Redeye interview with CEO Kristina Torfgård

Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more
Scientific presentations

2020-11-04

Study design for the first clinical study with the oligomer-specific therapeutic vaccine ALZ-101 presented at Clinical Trials in Alzheimer’s Disease (CTAD) 2020

Alzinova presented the study design of the upcoming first clinical study with the oligomer-specific therapeutic vaccine ALZ-101 on a… Read more
Scientific presentations

2020-10-15

Redeye Neurology Seminar CNS, October 15, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye's Neurology Seminar CNS on October 15 - in Swedish… Read more
Investor presentations

2020-10-06

Investor Presentation, October 6, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum Special - in Swedish… Read more
Investor presentations

2020-10-01

Investor Presentation, October 1, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum - in Swedish… Read more
Investor presentations

2020-09-29

Alzinova – About the Preferential Rights Issue

Kristina Torfgård, CEO talks briefly about the Preferential Rights issue in Redeye's "transaction pitch" - in Swedish. Read more
Investor presentations

2020-09-29

Alzinova – About the Company

Kristina Torfgård, CEO talks briefly about the company in Redeye's "Company pitch" - in Swedish. Read more
Investor presentations

2020-09-29

Alzinova – Elevator Pitch

Kristina Torfgård, CEO talks briefly about the company in Redeye's "elevator pitch" - in Swedish. Read more
Investor presentations

2020-09-29

Investor Presentation, September 29, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at the Redeye Investor Event - in Swedish… Read more
Investor presentations

2020-09-21

Aktiespararnas Aktiedag, September 21, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, September 21 2020 - World Alzheimer's Day… Read more
Scientific presentations

2020-07-30

Preclinical data presented at Alzheimer’s Association International Conference (AAIC) 2020

Dr. Anders Sandberg, Chief Scientific Officer, presented data on the Company's substances. The poster provides an overview of the… Read more
Investor presentations

Redeye interview with CEO Kristina Torfgård – webcast (in Swedish)

Alzinova's CEO Kristina Torfgård was interviewed on March 3, 2020 by Redeye’s Life Science analyst Anders Hedlund. Read more
Investor presentations

Redeye Growth Day, June 2 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at the Redeye Growth Day, Sweden. Read more